NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 953.65
+8.65 (0.92%)
Jul 20, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 170.27 billion as of July 20, 2026. Its market cap has decreased by -8.16% in one year.
Market Cap
170.27B
Enterprise Value
156.12B
Revenue
40.78B
Ranking
n/a
PE Ratio
12.00
Stock Price
953.65
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 170.27B, an increase of 39,554.25%. That is a compound annual growth rate of 24.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 170.27B | 5.27% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 338.08B |
| Wockhardt | 308.85B |
| Piramal Pharma | 238.12B |
| Eris Lifesciences | 201.67B |
| Cohance Lifesciences | 169.06B |
| Alembic Pharmaceuticals | 162.18B |
| Alivus Life Sciences | 139.10B |
| Akums Drugs and Pharmaceuticals | 101.81B |